135 related articles for article (PubMed ID: 24940587)
21. Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: Challenges in detecting dysplasia.
Adkins BD; Barlow AB; Jack A; Schultenover SJ; Desouki MM; Coogan AC; Weiss VL
Cytopathology; 2018 Jun; 29(3):281-287. PubMed ID: 29488269
[TBL] [Abstract][Full Text] [Related]
22. Hybrid capture 2 human papillomavirus DNA testing for women with atypical squamous cells of undetermined significance Papanicolaou results in SurePath and ThinPrep specimens.
Siddiqi A; Spataro M; McIntire H; Akhtar I; Baliga M; Flowers R; Lin E; Guo M
Cancer; 2009 Oct; 117(5):318-25. PubMed ID: 19693966
[TBL] [Abstract][Full Text] [Related]
23. Effects of transitioning from conventional methods to liquid-based methods on unsatisfactory Papanicolaou tests: results from a multicenter US study.
Owens CL; Peterson D; Kamineni A; Buist DS; Weinmann S; Ross TR; Williams AE; Stark A; Adams KF; Field TS
Cancer Cytopathol; 2013 Oct; 121(10):568-75. PubMed ID: 23658145
[TBL] [Abstract][Full Text] [Related]
24. Clinical results of a split sample liquid-based cytology (ThinPrep) study of 4,322 patients in a Turkish institution.
Tuncer ZS; Başaran M; Sezgin Y; Firat P; Mocan Kuzey G
Eur J Gynaecol Oncol; 2005; 26(6):646-8. PubMed ID: 16398228
[TBL] [Abstract][Full Text] [Related]
25. Only a small fraction of high-grade cervical lesions are discovered after an interpretation of atypical squamous cells of undetermined significance when using imager-assisted, liquid-based papanicolaou tests and the Bethesda 2001 system.
Khan KA; Smith DA; Thrall MJ
Arch Pathol Lab Med; 2013 Jul; 137(7):936-41. PubMed ID: 22994456
[TBL] [Abstract][Full Text] [Related]
26. ThinPrep Pap Test: performance and biopsy follow-up in a university hospital.
Carpenter AB; Davey DD
Cancer; 1999 Jun; 87(3):105-12. PubMed ID: 10385440
[TBL] [Abstract][Full Text] [Related]
27. Increased detection of epithelial cell abnormalities by liquid-based gynecologic cytology preparations. A review of accumulated data.
Austin RM; Ramzy I
Acta Cytol; 1998; 42(1):178-84. PubMed ID: 9479337
[TBL] [Abstract][Full Text] [Related]
28. Immunocytochemical detection of raf kinase inhibitor protein and human papillomavirus profiling of normal and abnormal cervical ThinPrep samples.
Al-Awadhi R; Husain S; Chehadeh W; Al-Jassar W; Kapila K; Al-Mulla F
Acta Cytol; 2013; 57(3):259-65. PubMed ID: 23636063
[TBL] [Abstract][Full Text] [Related]
29. Atypical glandular cells of undetermined significance in conventional cervical/vaginal smears and thin-layer preparations.
Hecht JL; Sheets EE; Lee KR
Cancer; 2002 Feb; 96(1):1-4. PubMed ID: 11836696
[TBL] [Abstract][Full Text] [Related]
30. Endocervical glandular involvement is associated with an increased detection rate of high-grade squamous intraepithelial lesions on the Papanicolaou test.
Jones R; Dale F; Fite JJ; Cowan ML; Williamson B; DeLuca J; VandenBussche CJ
J Am Soc Cytopathol; 2020; 9(3):137-145. PubMed ID: 32147423
[TBL] [Abstract][Full Text] [Related]
31. Comparison of fluid-based, thin-layer processing and conventional Papanicolaou methods for uterine cervical cytology.
Wang TY; Chen HS; Yang YC; Tsou MC
J Formos Med Assoc; 1999 Jul; 98(7):500-5. PubMed ID: 10463000
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of endocervical curettage for detecting dysplastic lesions in women with atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesion (LSIL) Papanicolaou smears.
Poomtavorn Y; Suwannarurk K; Thaweekul Y; Maireang K
Asian Pac J Cancer Prev; 2014; 15(8):3461-4. PubMed ID: 24870740
[TBL] [Abstract][Full Text] [Related]
33. Qualifying the cytologic diagnosis of "atypical squamous cells of undetermined significance" affects the predictive value of a squamous intraepithelial lesion on subsequent biopsy.
Genest DR; Dean B; Lee KR; Sheets E; Crum CP; Cibas ES
Arch Pathol Lab Med; 1998 Apr; 122(4):338-41. PubMed ID: 9648902
[TBL] [Abstract][Full Text] [Related]
34. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening.
Lee KR; Ashfaq R; Birdsong GG; Corkill ME; McIntosh KM; Inhorn SL
Obstet Gynecol; 1997 Aug; 90(2):278-84. PubMed ID: 9241308
[TBL] [Abstract][Full Text] [Related]
35. ProEx C immunocytochemistry and high-risk human papillomavirus DNA testing in papanicolaou tests with atypical squamous cell (ASC-US) cytology: correlation study with histologic biopsy.
Siddiqui MT; Hornaman K; Cohen C; Nassar A
Arch Pathol Lab Med; 2008 Oct; 132(10):1648-52. PubMed ID: 18834224
[TBL] [Abstract][Full Text] [Related]
36. False-positive Papanicolaou (PAP) test rates in the College of American Pathologists PAP education and PAP proficiency test programs: evaluation of false-positive responses of high-grade squamous intraepithelial lesion or cancer to a negative reference diagnosis.
Crothers BA; Booth CN; Darragh TM; Zhao C; Souers RJ; Thomas N; Moriarty AT
Arch Pathol Lab Med; 2014 May; 138(5):613-9. PubMed ID: 24786119
[TBL] [Abstract][Full Text] [Related]
37. Hyperchromatic crowded groups in cervical cytology--differing appearances and interpretations in conventional and ThinPrep preparations: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.
Renshaw AA; Mody DR; Wang E; Haja J; Colgan TJ;
Arch Pathol Lab Med; 2006 Mar; 130(3):332-6. PubMed ID: 16519560
[TBL] [Abstract][Full Text] [Related]
38. Can an inadequate cervical cytology sample in ThinPrep be converted to a satisfactory sample by processing it with a SurePath preparation?
Sørbye SW; Pedersen MK; Ekeberg B; Williams MEJ; Sauer T; Chen Y
Cytojournal; 2017; 14():20. PubMed ID: 28900466
[TBL] [Abstract][Full Text] [Related]
39. Restoring satisfactory status in ThinPrep Pap test specimens with too few squamous cells and containing microscopic red blood cells.
Pang Y; Smola B; Pu RT; Michael CW
Diagn Cytopathol; 2008 Oct; 36(10):696-700. PubMed ID: 18773435
[TBL] [Abstract][Full Text] [Related]
40. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.
Guo M; Shlyakhova N; Khanna A; Tinnirello AA; Schmeler KM; Hwang J; Sturgis EM; Stewart J
J Am Soc Cytopathol; 2021; 10(4):399-405. PubMed ID: 33967024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
